Cibus (CBUS)

Profile

Full Name

Cibus, Inc.

Ticker Symbol

CBUS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 20, 2017

Indexes

Not included

Website

http://www.cibus.com

Employees

157

Key Details

Price

$1.67(+3.73%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.26M(+134.56% YoY)

Annual EPS

-$10.83(+58.27% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.67
CBUS price is $1.67

30-Day Relative Volume

1.04
CBUS 30-day relative volume is 1.04

Price Performance

Price Most recent change

+3.73%
CBUS price was up +3.73% on Apr 17, 2025

Price YTD change

-39.93%
CBUS price is down -39.93% since January 1st

Price 1-year change

-89.3%
CBUS price is down -89.3% year-on-year

Price 3-year change

-94.94%
CBUS price is down -94.94% over the past 3 years

Price Range

Price All-time high

$1594.50
CBUS price is currently -99.90% below its historical high of $1594.50

Price 3-year low

$1.40
CBUS price is currently +19.29% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$54.51M
CBUS market capitalization is $54.51 million

Market cap 3-year change

+93.09%
CBUS market capitalization is up +93.09% over the past 3 years

Market cap All-time high

$871.84M
CBUS market capitalization is currently -93.75% below its historical high of $871.84 million

Market cap sector rank

39.51%
CBUS market capitalization is higher than 39.51% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+54.96%
CBUS shares outstanding is up +54.96% year-on-year

Shares Outstanding 3-Year Change

+3715.57%
CBUS shares outstanding is up +3715.57% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.63
CBUS beta is 1.63

200-day SMA

$4.32
CBUS price is currently -61.37% below its 200-day simple moving average

50-day SMA

$2.07
CBUS price is currently -19.14% below its 50-day simple moving average

RSI

42.59
CBUS 14-day relative strength index is 42.59

Volume

1.04
CBUS 30-day relative volume is 1.04

ATR

$0.20
CBUS average true range is $0.20

10-day Historical Volatility

111.37%
CBUS 10-day historical volatility is 111.37%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.26M
CBUS annual revenue is $4.26 million

Revenue Analysts estimate

$8.58M
CBUS annual revenue is currently -50.31% lower than the consensus analysts' forecast

Revenue 1-year change

+134.56%
CBUS annual revenue is up +134.56% year-on-year

Revenue Sector rank

20.74%
CBUS annual revenue is higher than 20.74% of companies in Healthcare sector

EPS

EPS

-$10.83
CBUS annual earnings per share is -$10.83

EPS Analysts estimate

-$1.16
CBUS annual earnings per share is currently +833.62% higher than the consensus analysts' forecast

EPS 1-year change

+58.27%
CBUS annual earnings per share is up +58.27% year-on-year

EPS Sector rank

11.27%
CBUS annual earnings per share is higher than 11.27% of companies in Healthcare sector

Profit

Gross profit

$4.26M
CBUS annual gross profit is $4.26 million

Gross margin

-
CBUS annual gross profit margin value is unknown

Operating profit

-$76.96M
CBUS annual operating income is -$76.96 million

Operating margin

-1805.82%
CBUS annual operating profit margin is -1805.82%

Net income

-$251.39M
CBUS annual net profit is -$251.39 million

Net margin

-5898.36%
CBUS annual net profit margin is -5898.36%

Expenses

Total expenses

$81.23M
CBUS annual total expenses is $81.23 million

Operating expenses

$81.23M
CBUS annual total operating expenses is $81.23 million

Cost of goods sold

-
CBUS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$30.80M
CBUS annual SGA is $30.80 million

Depreciation and amortization

$6.86M
CBUS annual depreciation & amortization is $6.86 million

Interest expense

$34.19M
CBUS annual interest expense is $34.19 million

Income tax

$29.00K
CBUS annual income tax is $29.00 thousand

EBIT & EBITDA

EBIT

-$248.49M
CBUS annual earnings before interest & taxes is -$248.49 million

EBITDA

-$241.63M
CBUS annual EBITDA is -$241.63 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$350.07M
CBUS annual total assets is $350.07 million

Non current assets

$333.12M
CBUS annual long term assets is $333.12 million

Current assets

$16.95M
CBUS annual total current assets is $16.95 million

Cash and cash equivalents

$14.43M
CBUS annual cash & cash equivalents is $14.43 million

Accounts receivable

$1.04M
CBUS annual accounts receivable is $1.04 million

Inventory

-
CBUS annual inventory value is unknown

Liabilities

Total liabilities

$252.24M
CBUS annual total liabilities is $252.24 million

Long term liabilities

$232.36M
CBUS annual total long term liabilities is $232.36 million

Current liabilities

$19.88M
CBUS annual total current liabilities is $19.88 million

Accounts payable

$5.96M
CBUS annual accounts payable is $5.96 million

Debt

Total debt

$36.29M
CBUS annual total debt is $36.29 million

Total debt 1-year change

+47.38%
CBUS annual total debt is up +47.38% year-on-year

Long term debt

$31.45M
CBUS annual long term debt is $31.45 million

Short term debt

$4.84M
CBUS annual short term debt is $4.84 million

Equity & Capital

Shareholders equity

$92.16M
CBUS annual stockholders equity is $92.16 million

Book value

$92.16M
CBUS annual book value is $92.16 million

Retained earnings

-$731.17M
CBUS annual retained earnings is -$731.17 million

Working capital

-$2.93M
CBUS annual working capital is -$2.93 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$58.04M
CBUS annual cash flow from operations is -$58.04 million

Cash from operations 1-year change

-25.61%
CBUS annual cash flow from operations is down -25.61% year-on-year

Cash from investing

-$808.00K
CBUS annual cash flow from investing activities is -$808.00 thousand

Cash from investing 1-year change

-101.47%
CBUS annual cash flow from investing activities is down -101.47% year-on-year

Cash from financing

$40.60M
CBUS annual cash flow from financing activities is $40.60 million

Cash from financing 1-year change

+99.79%
CBUS annual cash flow from financing activities is up +99.79% year-on-year

CAPEX

CAPEX

$808.00K
CBUS annual capital expenditures is $808.00 thousand

CAPEX 1-year change

-81.3%
CBUS annual capital expenditures is down -81.3% year-on-year

Free Cash Flow

Free cash flow

-$58.85M
CBUS annual free cash flow is -$58.85 million

Free cash flow 1-year change

-16.47%
CBUS annual free cash flow is down -16.47% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CBUS annual gross profit margin value is unknown

Operating margin

-1805.82%
CBUS annual operating profit margin is -1805.82%

Net margin

-5898.36%
CBUS annual net profit margin is -5898.36%

ROA & ROE

ROA

-56.21%
CBUS annual return on assets is -56.21%

ROE

-115.28%
CBUS annual return on equity is -115.28%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CBUS price to earnings ratio value is unknown

PE ratio Sector rank

-
CBUS price to earnings ratio is unknown

PB Ratio

PB ratio

0.59
CBUS price to book ratio is 0.59

PB ratio Sector rank

32.32%
CBUS price to book ratio is higher than 32.32% of companies in Healthcare sector

PS Ratio

PS ratio

12.79
CBUS price to sales ratio is 12.79

PS ratio Sector rank

82.54%
CBUS price to sales ratio is higher than 82.54% of companies in Healthcare sector

Enterprise value

Enterprise value

$76.36M
CBUS enterprise value is $76.36 million

Enterprise value Sector rank

46.36%
CBUS enterprise value is higher than 46.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.32
CBUS EV/EBITDA is -0.32

EV/EBITDA Sector rank

55.53%
CBUS EV/EBITDA is higher than 55.53% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.85
CBUS annual current ratio is 0.85

Quick ratio

-
CBUS annual quick ratio value is unknown

Leverage

Debt to equity

0.01
CBUS annual debt to equity ratio is 0.01

Interest coverage ratio

-7.27
CBUS annual interest coverage ratio is -7.27

Risk & Stability

Piotroski F-Score

-
CBUS piotroski f-score value is unknown

Altman Z-Score

-5.13
CBUS altman z-score is -5.13

Analyst ratings

Recent major analysts updates

Mar 21, 25 HC Wainwright & Co.
Buy
Jan 22, 25 Canaccord Genuity
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Oct 22, 24 Canaccord Genuity
Buy
Sep 24, 24 Alliance Global Partners
Buy
Sep 19, 24 Canaccord Genuity
Buy
Aug 12, 24 Canaccord Genuity
Buy
Jul 29, 24 Alliance Global Partners
Buy
May 10, 24 HC Wainwright & Co.
Buy
Mar 22, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Artiva Biotherapeutics (ARTV)
ABOS logo
Acumen Pharmaceuticals (ABOS)
BEAT logo
HeartBeam (BEAT)
HYPR logo
Hyperfine (HYPR)
KRON logo
Kronos Bio (KRON)
AKYA logo
Akoya Biosciences (AKYA)
NEUE logo
NeueHealth (NEUE)
OWLT logo
Owlet (OWLT)
IKNA logo
Ikena Oncology (IKNA)
  • What is the ticker symbol for Cibus?
  • Does Cibus pay dividends?
  • What sector is Cibus in?
  • What industry is Cibus in?
  • What country is Cibus based in?
  • When did Cibus go public?
  • Is Cibus in the S&P 500?
  • Is Cibus in the NASDAQ 100?
  • Is Cibus in the Dow Jones?
  • When was Cibus's last earnings report?
  • When does Cibus report earnings?
  • Should I buy Cibus stock now?

What is the ticker symbol for Cibus?

The ticker symbol for Cibus is NASDAQ:CBUS

Does Cibus pay dividends?

No, Cibus does not pay dividends

What sector is Cibus in?

Cibus is in the Healthcare sector

What industry is Cibus in?

Cibus is in the Biotechnology industry

What country is Cibus based in?

Cibus is headquartered in United States

When did Cibus go public?

Cibus's initial public offering (IPO) was on July 20, 2017

Is Cibus in the S&P 500?

No, Cibus is not included in the S&P 500 index

Is Cibus in the NASDAQ 100?

No, Cibus is not included in the NASDAQ 100 index

Is Cibus in the Dow Jones?

No, Cibus is not included in the Dow Jones index

When was Cibus's last earnings report?

Cibus's most recent earnings report was on Mar 20, 2025

When does Cibus report earnings?

The next expected earnings date for Cibus is May 9, 2025

Should I buy Cibus stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page